Quinine has become again the mainstay in treatment of multidrugresistant falciparum malaria in the eighties. During quinine treatment minor sideeffects frequently occur whereas serious side-effects such as irreversible deafness and amblyopia are rare. Using normal or low doses of quinine a syndrome termed as cinchonism is commonly observed. Mild forms consist of tinnitus, headache, nausea and visual and auditory disturbances. Here we describe a case of transient organic brain syndrome which occurred during quinine treatment.
mood and subjective wellbeing seemed to be unchan ged. Psychomotor activity was slightly decreased without any signs of anxiety or suspicion. On the day of admission quinine medication was stopped. Daily observation revealed a continuous reduction of symptoms during a seven day period. Only a retro grade amnesia remained. Severe neuropsychiatric states are infrequent side effects of cinchona alkaloids and related compounds. However, although mefloquine had not yet been widely used, an acute brain syndrome after mefloquine intake is reported1.
Furthermore a quinidine induced delirium has been described2. To our knowledge this is the first report of a transient organic brain syndrome occuring during quinine medication. For us this syndrome was considered to be caused by quinine for the following reasons: 
